Shares of Bengaluru Based pharma company Syngene Ltd down 10% in early trade,Share of Syngene Ltd trading at ₹674.50 and Company looses market cap of Over ₹3,000 Crore.This Selling Comes after company's Weak Q4 Results 

Syngene Q4 Results 

Net Profit Down by 3% to ₹183 Crore and Total Revenue Rises to ₹1,037 Crore and For Financial year 2025 Syngene International limited posts net Profit of ₹496 Crore which down from ₹510 Crore last financial year 

Company Also declared Dividend of ₹1.25 Per Share 

Management Said that This full year results led by reported 4% growth in revenue which is inline to company's Estimates Further management Said after seeing muted growth in first half we're encouraging to see growth in second half 

But for growth prospective management sees only mid single digit in revenue 

Tracking this cautious management Commentry shares of Syngene International limited falls 10% in today's trading Session; In last 6 months Stocks down more 23%

Declaimer:This article is only for information Purpose